Company / EPS (Diluted)
Q32 Bio Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$6.58
FY2025
5-year range
-$153.96 / -$0.09
FY2021-FY2025
Trend
+95.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 8 years, ranging from $-153.96 in FY2024 to $-0.09 in FY2023.
Based on SEC 10-K filings.
-6.58 in FY2025.
Declined from $-0.09 to $-6.58 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 95.7% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.58 | +95.7% |
| FY2024 | -$153.96 | -170966.7% |
| FY2023 | -$0.09 | +94.8% |
| FY2022 | -$1.73 | +38.2% |
| FY2021 | -$2.80 | -13.4% |
| FY2020 | -$2.47 | -26.7% |
| FY2019 | -$1.95 | +83.9% |
| FY2018 | -$12.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026